TABLE 1 LAMEA Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 4 LAMEA Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 5 LAMEA Macular Degeneration Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Macular Degeneration Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Diabetic Retinopathy Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Diabetic Retinopathy Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 12 LAMEA Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 13 LAMEA VEGF-A Antagonist Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA VEGF-A Antagonist Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 LAMEA Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Retinal Biologics Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Retinal Biologics Market by Country, 2023 - 2030, USD Million
TABLE 27 Brazil Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 28 Brazil Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 29 Brazil Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 30 Brazil Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 31 Brazil Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 Brazil Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 Brazil Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Brazil Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Argentina Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 36 Argentina Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 37 Argentina Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 38 Argentina Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 39 Argentina Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 40 Argentina Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 41 Argentina Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Argentina Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 UAE Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 44 UAE Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 45 UAE Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 46 UAE Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 47 UAE Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 48 UAE Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 49 UAE Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 UAE Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Saudi Arabia Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 52 Saudi Arabia Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 53 Saudi Arabia Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 54 Saudi Arabia Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 55 Saudi Arabia Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 South Africa Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 60 South Africa Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 61 South Africa Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 62 South Africa Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 63 South Africa Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 64 South Africa Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 65 South Africa Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 South Africa Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Nigeria Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 68 Nigeria Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 69 Nigeria Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 70 Nigeria Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 71 Nigeria Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 72 Nigeria Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 73 Nigeria Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Nigeria Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Rest of LAMEA Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 76 Rest of LAMEA Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 77 Rest of LAMEA Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 78 Rest of LAMEA Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 79 Rest of LAMEA Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Key Information – Novartis AG
TABLE 84 Key Information – Amgen, Inc.
TABLE 85 Key information – AbbVie, Inc.
TABLE 86 Key Information – Bayer AG
TABLE 87 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 88 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 89 key information – Bausch Health Companies, Inc.
TABLE 90 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 91 Key Information – MeiraGTx Holdings plc
TABLE 92 Key Information – Oxurion NV
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Retinal Biologics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Retinal Biologics Market
FIG 4 Porter’s Five Forces Analysis - Retinal Biologics Market
FIG 5 LAMEA Retinal Biologics Market share by Indication, 2022
FIG 6 LAMEA Retinal Biologics Market share by Indication, 2030
FIG 7 LAMEA Retinal Biologics Market by Indication, 2019 - 2030, USD Million
FIG 8 LAMEA Retinal Biologics Market share by Drug Class, 2022
FIG 9 LAMEA Retinal Biologics Market share by Drug Class, 2030
FIG 10 LAMEA Retinal Biologics Market by Drug Class, 2019 - 2030, USD Million
FIG 11 LAMEA Retinal Biologics Market share by Distribution Channel, 2022
FIG 12 LAMEA Retinal Biologics Market share by Distribution Channel, 2030
FIG 13 LAMEA Retinal Biologics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 LAMEA Retinal Biologics Market share by Country, 2022
FIG 15 LAMEA Retinal Biologics Market share by Country, 2030
FIG 16 LAMEA Retinal Biologics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novartis AG
FIG 18 Swot Analysis: Amgen, Inc.
FIG 19 Swot Analysis: AbbVie, Inc.
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 22 Swot Analysis: Santen Pharmaceutical Co., Ltd.
FIG 23 Recent strategies and developments: Bausch Health Companies, Inc.
FIG 24 Swot Analysis: Bausch Health Companies, Inc.
FIG 25 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 26 Swot Analysis: MeiraGTx Holdings plc
FIG 27 Swot Analysis: Oxurion NV
Unique Offerings 